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ABSTRACT 22 
Alterations of brain network activity are observable in Alzheimer’s disease (AD) together with the 23 
occurrence of mild cognitive impairment, before overt pathology.  However, in humans as well in AD mouse 24 
models identification of early biomarkers of network dysfunction is still at its beginning. We performed in 25 
vivo recordings of local field potential (LFP) activity in the dentate gyrus (DG) of PS2APP mice expressing 26 
the human amyloid precursor protein (APP) Swedish mutation and the presenilin-2 (PS2) N141I. From a 27 
frequency-domain analysis, we uncovered network hyper-synchronicity as early as 3 months, when 28 
intracellular accumulation of amyloid-beta (Aβ) was also observable. Additionally, at 6 months of age, we 29 
identified network hyper-activity in the Beta/Gamma frequency bands, along with increased Theta-Beta 30 
and Theta-Gamma phase-amplitude cross-frequency coupling (CFC), in coincidence with the histo-31 
pathological traits of the disease. Whereas hyper-activity and hyper-synchronicity were respectively 32 
detected in mice expressing the PS2-N141I or the APP Swedish mutant alone, the increase in CFC 33 
specifically characterized the 6-month-old PS2APP mice, just before the surge of the cognitive decline.  34 
 35 
 36 
Keywords: Alzheimer’s disease, local field potential, dentate gyrus, PS2APP, hyper-excitability, amyloid-beta 37 
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1 INTRODUCTION 38 
Alzheimer’s disease (AD) is a neurodegenerative pathology that affects an increasing number of elderly 39 
people. It is characterized by progressive impairment in cognition and memory and it is the most frequent 40 
cause of dementia, being responsible for 60 to 70 % of the cases over 65 years (World Health Organization, 41 
2015). After the failure of Aβ-targeting therapies in clinical trials, one possible explanation is the fact that 42 
the treated patients had already fully developed the disease, as revealed by combined fMRI and cognitive 43 
assessment (Golde et al., 2011). These discouraging results highlight the urgency of early biomarkers that 44 
reliably indicate the undercover developing disease and that predict the overt onset of the first clinical 45 
symptoms with years of advance. From this perspective, PET/CSF and brain volumetric biomarkers proved 46 
to be valuable tools for predicting MCI to AD conversion over 2 years (Mitchell et al., 2010). Yet, the 47 
moment when the brain has already started to shrink is anyhow likely to be very late, implying that a 48 
hypothetically effective disease-modifying therapy would yield no appreciable improvement because of the 49 
other detrimental mechanisms that have, meanwhile, established. Likewise, alterations in oscillatory brain 50 
activity were assessed in subjects already presenting symptoms of cognitive decline (Bhat et al., 2015). 51 
AD mouse models provide the possibility to address potential changes of brain network activity that 52 
precede amyloid deposition and cognitive defects. Ca
2+
 hyper-activity and hyper-excitability appear to be 53 
among the first alterations observable at the brain level (Stargardt et al., 2015). Dysregulation of Ca
2+
 54 
signaling, which is closely linked to mitochondrial dysfunction and ROS formation, has been implicated in 55 
the aged and diseased brain (Agostini and Fasolato, 2016, Decuypere et al., 2011) and consistently reported 56 
in different AD mouse models (Busche et al., 2015, Busche et al., 2012, Camandola and Mattson, 2011, 57 
Kipanyula et al., 2012, Stargardt et al., 2015, Zampese et al., 2011a). A FAD-linked mutation in PS2 has been 58 
shown to cause profound alteration of Ca
2+
 signaling in fibroblasts obtained from FAD patients, well before 59 
the onset of the cognitive decline (Giacomello et al., 2005). Other FAD-linked PS2 mutations show similar 60 
Ca
2+
 defects (Kipanyula et al., 2012, Zampese et al., 2011b, Zatti et al., 2006). Recently, early neuronal 61 
impairment of Ca
2+
 homeostasis has been described in AD mouse models based on PS2-N141I, with 62 
increased Ca
2+
 excitability proved both in vitro and in situ (Kipanyula et al., 2012). Thus, we reasoned that 63 
addressing hyper-activity due to Ca
2+
 as well as Aβ dysregulation, brought about by mutant PS2 in young 64 
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mice, might help defining early markers of disease progression. In particular, we asked whether and from 65 
which stage of the disease it is possible to detect early network dysfunctions in the homozygous AD mouse 66 
line PS2APP (B6.152H), expressing the hPS2-N141I in the presence of the hAPP Swedish mutation 67 
(hAPPSwe) (Kipanyula et al., 2012, Ozmen et al., 2009, Richards et al., 2003). While the C57BL/6J mice were 68 
regularly used as a control, a comparison was also carried out with other homozygous mouse lines, the PS2-69 
NI (PS2.30H) and the hAPPSwe (BD.AD147.72H) lines, expressing either the PS2-N141I or the hAPPSwe, 70 
respectively (Richards et al., 2003), and the PS2 knockout (PS2KO) mouse line (Herreman et al., 1999).  71 
By recording in vivo the spontaneous LFP activity in the DG of mice under urethane anesthesia, we 72 
investigated the brain oscillatory activity in terms of power spectral density (PSD) and phase-amplitude CFC 73 
(PAC). Of note, PS2APP mice were analyzed before and after the onset of Aβ deposition and gliosis, and 74 
compared to age-matched control and single transgenic (tg) mice. To our knowledge, only few studies have 75 
addressed spontaneous hippocampal oscillatory activity in AD mouse models in vivo at the early stages of 76 
the disease (Born et al., 2014, Ittner et al., 2014, Verret et al., 2012, Xu et al., 2015). Importantly, this is the 77 
first study addressing the role of PS2 on brain excitability in AD tg mouse models. 78 
2 METHODS 79 
2.1 ANIMALS 80 
The homozygous tg mouse lines PS2APP (B6.152H) and APPSwe (BD.AD147.72H) were kindly donated by L. 81 
Ozmen (F. Hoffmann-La Roche Ltd, Basel, Switzerland) (Richards et al. 2003; Ozmen et al., 2009). The 82 
homozygous tg lines PS2-NI (PS2.30H) (Ozmen et al., 2009) and PS2KO (Herreman, et al. 1999) were 83 
obtained by embryo revitalization from Charles River Laboratories (CRL, Lecco, Italy) and CNR-EMMA 84 
repository (Rome, Italy), respectively. In these lines, APP and PSEN2 transgenes are driven by mouse Thy-1 85 
and mouse prion promoters, respectively. All lines were originally backcrossed to C57BL/6J (wt) mice for 4 86 
or more generations, the resulting backgrounds are reported in Supplementary Table 1. As a control, we 87 
used a wt colony established in our SPF animal facility from littermates obtained following PS2-NI 88 
backcrossing. For all lines, inbreeding was avoided and age-matched females were used without checking 89 
estrous cycle. Specific work on similar type of recordings (Gurevicius et al., 2013) and meta-analysis studies 90 
(Prendergast et al., 2014) indicate that estrous cycle does not increase female variability. All experimental 91 
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procedures were carried out in strict adherence to the Italian regulations on animal protection and care 92 
and with the explicit approval of the Italian animal welfare regulations (Decreto autorizzativo 447/2015-93 
PR). 94 
Acute animal preparation. Female mice were anesthetized by intraperitoneal injection of urethane (1.5-2 95 
mg/g, U2500 - Sigma-Aldrich) dissolved in 0.9% NaCl physiological saline. An initial dose of 1.2 mg/g was 96 
injected and additional doses (0.15 mg/g) were administered when required (Namgung et al., 1995). 97 
Absence of reaction to noxious stimuli (e.g. hind paw pinches) ensured the surgical plane of anesthesia. 98 
Body temperature was kept at 37 ± 0.5°C by means of a servo-controlled heating pad (ATC1000 – World 99 
Precision Instruments, Inc.). Krebs solution (0.1 ml) was subcutaneously administered every two hours in 100 
order to maintain hydration levels. The head was restrained in a stereotaxic frame and the skull was 101 
exposed. A hole was drilled at the site for inserting the recording electrode in the DG which was located 102 
about 2.4 mm posterior to bregma and 1.2 mm lateral to midline (Huang et al., 2012). The left hemisphere 103 
was selected provided that amyloid plaques deposition is stronger in this hemisphere (Khan et al., 2014). 104 
The cavity over the skull was filled with Krebs saline solution and a silver chloride reference electrode was 105 
dipped within. Glass electrodes for LFP recording (0.9-1.6 MΩ tip resistance) were obtained from 106 
borosilicate capillaries (GB150T-10 – Science Products GmbH) pulled with a P-97 micropipette puller (Sutter 107 
Instrument Company) and filled with Krebs solution. In each animal, the LFP signal was serially acquired at 108 
three different depths from the meninges: 1.7, 1.8 and 1.9 mm. These depths correspond to the molecular 109 
layer, the granule cell layer and the polymorphic layer of the DG. 110 
Heart beat was monitored through electrocardiogram (ECG) recording. ECG positive and negative 111 
derivations were subcutaneously inserted in the forelimbs. A high accuracy temperature probe was leaned 112 
against the chest wall, on the side of the body, to monitor respiration (IT-23, World Precision Instruments). 113 
At the end of the electrophysiological experiment, mice were euthanized by excess of anesthesia and the 114 
brain was dissected. The left hemisphere was intended for histological investigations and was fixed in 4% 115 
paraformaldehyde [PFA) in Tris-buffer saline, TBS: NaCl (150 mM), Tris (50 mM), pH adjusted to 7.4 with 116 
HCl]. Conversely, the right-hemisphere cortex and hippocampus were snap-frozen in liquid nitrogen for 117 
biochemical assays. 118 
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2.2 ELECTROPHYSIOLOGY 119 
Data acquisition. The LFP signal was 10X amplified using an Axoclamp-2B amplifier with an HS-2Ax1LU 120 
headstage (Axon Instruments Inc.) in bridged mode. A custom-made amplifier provided further 10X 121 
amplification along with 4-pole butterworth low-pass filtering at 1 kHz. The ECG signal was 10X amplified 122 
and band-passed between 1 and 100 Hz by means of a DAM50 amplifier (World Precision Instruments). 123 
Respiration-induced movements of the chest wall were converted in voltage fluctuation by exploiting the 124 
piezoelectric properties of the temperature probe. Respiration signal was 100X amplified and band-passed 125 
between 0.1 and 100 Hz by means of a DP-301 amplifier (Warner Instruments). Signals were digitalized at 126 
10 kHz by means of a PCI-6071E I/O card (-0.5 – 0.5 V input range) combined with a BNC-2090 terminal 127 
block (National Instruments) in differential mode and recorded through a custom-made LabView (National 128 
Instruments) script. Each recording lasted 15 minutes on average. See Supplementary Methods for 129 
electrophysiological data analysis. 130 
2.3 IMMUNOHISTOCHEMISTRY 131 
Mid-sagittal brain slices were cut from the left hemisphere and conserved in TBS at 4 °C until employed for 132 
dorsal hippocampus immunostaining. For staining, floating slices were selected over a range of 400 µm. 133 
First, Slices, washed in TBS and incubated for 5 minutes in 70% formic acid, were incubated in blocking 134 
buffer containing 0.3% TritonX-100 and 5% goat serum in TBS for 1 hour at room temperature (RT). Next, 135 
they were incubated overnight at 4°C with mouse anti-Aβ 17-24 (4G8, Covance, 1:1000) and rabbit anti-136 
GFAP (Dako, 1:400). Then, slices were incubated, for 1 h at RT in the dark, with donkey anti-rabbit Alexa488 137 
(Invitrogen, 1:1000) and goat anti-mouse Alexa555 (Invitrogen, 1:1000). Mowiol-mounted slices were 138 
stored at 4°C until visualization by means of Leica SP5 (20X). For astrogliosis quantification, we considered 139 
the average brightness level of GFAP labelling in the HF region. In each image, a region of interest (ROI) was 140 
traced encompassing the following regions: subiculum, DG, CA3 and CA1; for the cortex, a rectangular ROI 141 
of invariant size was drawn. Then, the average 8-bit pixel intensity (0-255) was computed for each ROI. 142 
Three slices for each mouse (n=3 mice per line) were used to quantify the mean average value of the 143 
selected regions (Fiji). Slices from the wt, PS2-NI, PS2APP and/or APPSwe mice were processed in parallel. 144 
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2.4 STATISTICAL ANALYSES 145 
Statistical analyses were carried out in Prism (GraphPad). Power spectra, band power, PSD slope, PSD offset 146 
and PAC indices, obtained from the recordings at the three depths, were averaged within animals to obtain 147 
grand mean quantifications for each animal. Differences among means were tested by performing Kruskal-148 
Wallis nonparametric test. Where Kruskal-Wallis test resulted in the existence of a pair of different 149 
populations, differences between means where tested with Mann-Whitney Rank Sum test. Correlation 150 
between variables was assessed by means of the Spearman's rank correlation coefficient. The unpaired 151 
two-tailed Mann-Whitney Rank Sum test was employed for mean brightness intensities. All data are 152 
expressed as mean ± SEM. The α level of significance was 0.05 (*p < 0.05; ** p<0.01; *** p< 0.001; **** 153 
p<0.0001). 154 
3 RESULTS 155 
3.1 IN VIVO LFP RECORDINGS IN THE DG OF PS2-BASED AD MICE 156 
Compelling evidence was provided for dysregulation of neuronal Ca
2+ 
homeostasis along with network Ca
2+
 157 
hyper-activity in hippocampal slices from 2-week-old PS2APP and PS2-NI mice (Kipanyula et al., 2012). In 158 
order to address in vivo the existence of alterations in network activity, we recorded spontaneous 159 
hippocampal LFPs from the DG of wt, PS2-NI and PS2APP mice at 3, 6 and 12 months of age, under 160 
urethane anesthesia (Supplementary Fig. 1 and Methods). To keep the groups more homogeneous, only 161 
female mice were considered given the fact that, in females, anticipation of the pathology characterizes the 162 
disease in humans as well as PS2APP mice (Ozmen et al., 2009).  All the below reported analyses are based 163 
on the following numbers of mice: 11, 8, 8 (3-month-old); 10, 12, 12 (6-month-old) and 9, 7, 9 (12-month-164 
old) for wt, PS2-NI and PS2APP lines respectively, with a tolerance of 1 week for the 3 month-group, 2 165 
weeks for the 6 and 4 weeks for the 12 month-groups. 166 
3.2 POWER SPECTRAL DENSITY 167 
We evaluated the overall neural population activity in the DG by analyzing the PSD function obtained from 168 
the LFP traces recorded during stable and regular heart and respiration rates (see Supplementary Methods 169 
and Supplementary Fig. 1). Analysis of the different frequency bands was carried out in the following 170 
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intervals: Slow Oscillations (SO, 0.1-1.4 Hz), Theta (1.7-4.7 Hz), Beta (10-25 Hz), Slow-Gamma (SG, 25-40 171 
Hz), Fast-Gamma (FG, 45-90 Hz) and Epsilon (110-190 Hz) (Supplementary Fig. 1C). At a first glance, with 172 
respect to wt mice, the PSD plots showed a marked broad-band power increase in the range from 15 to 60 173 
Hz, in both PS2-NI and PS2APP mice at 6 months of age but only in PS2APP mice at 3 months of age (Fig. 1, 174 
A-C). Quantification of the power within discrete frequency bands revealed that, for 6 month-old PS2-NI 175 
mice, the increase was statistically significant (p < 0.05, Mann-Whitney rank-sum test) in the SG (PS2-NI, 176 
1.12e-3 ± 0.19; wt , 0.58e-3 ± 0.17e-3 mV
2
) and in the FG (PS2-NI, 1.08e-3 ± 0.18e-3; wt, 0.59e-3 ± 0.19e-3 177 
mV
2
) ranges and, for 6 month-old PS2APP mice, in the Beta (PS2APP, 2.59e-3 ± 0.31e-3; wt, 1.18e-3 ± 178 
0.32e-3 mV
2
) and SG (PS2APP, 1.35e-3 ± 0.18e-3; wt, 0.58e-3 ± 0.17e-3 mV
2
) ranges (Fig. 1, D-F). In these 179 
frequency bands, no alterations were observed at 12 months of age for both tg lines, whereas the 180 
remaining frequency bands (SO, Theta and Epsilon) stayed unaltered at all ages (Supplementary Fig. 3A-C). 181 
We further investigated whether the steepness of the PSD function could also be altered, since it was 182 
shown that several neurological diseases and disturbs, including Parkinson’s disease and schizophrenia, 183 
affect PSD steepness, especially in the Gamma range  (Voytek and Knight, 2015). The PSD log-log plots 184 
shown in Figure 1 presented a corner frequency around 30-40 Hz, which prevented a proper linear fitting in 185 
the Gamma frequency range. The steepness of the 1/f
x
 noise function was thus estimated following linear 186 
fitting of PSD plots in the semi-log space (10-100 Hz), as previously described (Voytek et al., 2015). As 187 
shown in Figure 2, comparison of the slope coefficients revealed that the power decay was significantly 188 
steeper in PS2APP mice compared to wt at both 3 and 6 months of age (PS2APP, -0.26 ± 0.01; wt, -0.21 ± 189 
0.01 at 3 months and PS2APP, -0.24 ± 0.01; wt, -0.20 ± 0.01 at 6 months, mean ± SEM, p < 0.05, Mann-190 
Whitney rank-sum test). A tendency in the same direction, albeit not significant, was also clear at 12 191 
months of age. In contrast, in PS2-NI mice, PSD steepness was comparable to that found in wt mice at each 192 
considered age. All in all, these results indicate an overall alteration of DG network synchronicity under 193 
urethane anesthesia, as inferable through the analysis of the PSD slope coefficient, in PS2APP, but not PS2-194 
NI mice, as soon as 3 months of age. We also compared the PSD functions for the same genotype across 195 
different ages in the log-log and semi-log space (Supplementary Fig. 4, A-F). Upon linear fitting, as described 196 
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in the previous paragraph, we noticed that in PS2APP mice, the increase in steepness was lost at 12 months 197 
(PS2APP, -0.22 ± 0.01; wt, -0.20 ± 0.01, Supplementary Fig. 4G). 198 
Finally, offset values were compared per genotype, across ages (Fig. 2E). Two pieces of information clearly 199 
emerged: i) at 3 and 6 months of age, PS2APP mice have a much higher offset compared to wt and PS2-NI 200 
mice (PS2APP, 7.49e-4 ± 1.32e-4; PS2-NI, 3.37e-4 ± 0.57e-4; wt, 3.75e-4 ± 0.54e-4 mV
2
/Hz at 3 months and 201 
PS2APP, 4.81e-4 ± 0.65e-4; PS2-NI, 3.24e-4 ± 0.62e-4; wt, 1.50e-4 ± 0.41e-4 mV
2
/Hz at 6 months; p < 0.05, 202 
Mann-Whitney rank-sum test); ii) in wt mice, the offset rapidly decreased with age (for a better 203 
comparison, the same data were plotted per age in Supplementary Fig. 4H, p < 0.05, Mann-Whitney rank-204 
sum test), whereas the decline was delayed in PS2APP  mice, and the offset showed a significant reduction 205 
only at 12 months; in PS2-NI mice,  offset reduction with age was not statistically significant.   206 
3.3 PHASE AMPLITUDE COUPLING 207 
In addition to the analysis of the spectral changes, we considered another feature of brain LFP signals that 208 
are nested oscillations, where a slower rhythm influences a faster one in a dynamic fashion. We asked 209 
whether the spectral alterations that we observed could be accompanied by changes in CFC - i.e. the 210 
relationship within each pair of nested oscillations - between the phase of one oscillation and the 211 
amplitude of a higher frequency. We quantified the PAC in the Theta-Beta, -SG, -FG and -Epsilon classes by 212 
computing the General Linear Model (GLM) index (Penny et al., 2008) (Supplementary Methods). 213 
In PS2APP mice at 6 months of age, the pattern of alteration of the PAC level in the different classes closely 214 
resembled that of power (Fig. 1D, E & Fig. 3A, B). In fact, compared to wt mice, PAC resulted significantly 215 
enhanced for both the Theta-Beta (PS2APP, 0.17 ± 0.02; wt, 0.10 ± 0.01) and the Theta-SG range (PS2APP, 216 
0.21 ± 0.03; wt, 0.13 ± 0.02, p < 0.05, Mann-Whitney rank-sum test). In contrast, PS2-NI mice did not 217 
present any significant difference in the PAC level (p ≥ 0.05, Mann-Whitney rank-sum test) with respect to 218 
wt mice, either at 3 or 6 months of age. Despite the increase of SG and FG power in 6-month-old PS2-NI 219 
mice, the level of PAC in the classes concerning those bands resulted unaffected. Finally, only the PS2APP 220 
mice reported a significant reduction of Theta-Epsilon PAC at 12 months (PS2APP, 0.10 ± 0.01; wt, 0.15 ± 221 
0.01) (Fig. 3D). 222 
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Interestingly, following Spearman rank correlation analysis, offset values significantly correlated with power 223 
(p < 0.05, permutation test), particularly in the Gamma range for all genotypes (Supplementary Fig. 5A), 224 
reinforcing the notion that PSD offset reflects local population spiking activity (Voytek and Knight, 2015). 225 
Theta-SG PAC significantly correlated with Theta, yet not SG (Supplementary Fig. 5D, E), nor FG power (data 226 
not shown). Further, a significant correlation was also found between Theta-SG PAC and steepness only for 227 
the PS2APP line (Supplementary Fig. 5F). 228 
3.4 AMYLOID BETA ACCUMULATION AND ASTROGLIOSIS 229 
Among the major histo-pathological hallmarks of AD are the extracellular deposition of amyloid plaques 230 
and the establishment of gliosis, i.e. the sustained inflammatory glial response to insulting conditions. We 231 
evaluated the deposition of amyloid plaques as well as the presence of astrogliosis by IHC (see Methods) in 232 
hippocampal slices of PS2APP, PS2-NI and wt mice at 3 and 6 months of age, in correspondence with the 233 
main electrophysiological traits emerged from our analysis. 234 
We consistently found marked plaque deposition in the hippocampal formation (HF), especially in the 235 
subiculum and, to a lesser degree, in the DG, as well as in the cerebral cortex of 6-month-old PS2APP mice 236 
when compared to age-matched wt mice (Fig. 4A, C, left). These findings confirm and expand previous 237 
observations obtained in the brain of PS2APP mice by the Congo red approach, which primarily detects the 238 
fibrillary deposits (Ozmen et al., 2009). In contrast, extracellular amyloid aggregates were not observed in 239 
PS2-NI mice at this age (Fig. 4B, left), as well as at 12 months (data not shown). In 3 month-old PS2APP 240 
mice, however, a noticeable intracellular amyloid staining was detected in all considered territories (Fig. 241 
5A), yet it was particularly strong in the subiculum (Fig. 5B) and in the pyramidal layer (sp, stratum 242 
pyramidalis) of the CA1 region, with a clear granular appearance (Fig. 5C). Interestingly, early detection of a 243 
strong intra-neuronal Aβ/APP signature that fades at subsequent ages has been previously reported in 244 
other AD mouse models based on mutant APP (Lord et al., 2006, Zou et al., 2015). 245 
In AD, astrocytes become reactive and increase the expression levels of the intermediate filament protein 246 
GFAP, a condition known as astrogliosis (Steardo Jr et al., 2015). We detected the GFAP expression level in 247 
hippocampal slices adjacent to those used for APP/Aβ detection (Fig. 4A-C, right). A quantitative analysis 248 
was carried out within specific regions, as defined in Methods and summarized in Figure 4D. We found a 249 
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statistically significant increase of mean intensity (p < 0.05, Mann-Whitney rank-sum test) in 6-month-old 250 
PS2APP mice, compared to age-matched wt mice, in subiculum (+ 44.2%), DG (+ 37.0%) and cortex (+ 251 
42.4%). 252 
It is largely accepted that synaptic loss and neuronal dysfunction in AD are mainly caused by accumulation 253 
of soluble forms of Aβ42, especially small oligomers, rather than by amyloid plaques. The accumulation of 254 
Aβ42 was thus evaluated at the hippocampal level by means of ELISA kits suited to measure both mouse and 255 
human Aβ42 (see Methods). As shown in Supplementary Figure 6, in wt and PS2-NI mice, Aβ42 levels were 256 
comparable at any age, being in the order of few pg/mg of wet tissue (n = 3 mice, each group). In contrast, 257 
compared to wt, the PS2APP mice showed a dramatic increase in Aβ42 levels, at both 3 and 6 months of 258 
age, being respectively 10
2
 and 10
3
 times the wt level. Between 6 and 12 months of age, the Aβ42 load 259 
continued to grow, yet at a lower rate, a result in agreement with previous observations (Ozmen et al., 260 
2009). These results identify the 3-6 month-period as the exponential phase of Aβ accumulation in PS2APP 261 
mice. Aβ40 accumulates in a similar way being the Aβ42/Aβ40 ratio close to 1 in this mouse model, at any age 262 
((Ozmen et al., 2009) and Supplementary Table 1.  263 
3.5 ROLE OF PS2 AND APP 264 
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At 6 months of age both PS2APP and PS2-NI mice were characterized by sustained power levels in the Beta-265 
Gamma frequency range, when compared to wt mice. Conversely, at the same age, wt mice showed a net, 266 
statistically significant, power decline within this frequency range with respect to 3-month-old mice 267 
(Supplementary Fig. 4A-C, H). Notably, only PS2APP mice showed an increased 1/f
x
 steepness, a property 268 
detected as early as 3 months (Fig. 2D and Supplementary Fig. 4G). Thus, the augmented spectral power 269 
correlated with the expression of the mutant PS2, whereas the increased steepness appeared to be a 270 
property linked to the expression of mutant APP.  To further strengthen these linkages, we carried out 271 
similar LFP recordings in 6-month-old females from PS2KO (n = 7) (Herreman et al., 1999) and APPSwe (n = 272 
5) (Ozmen et al., 2009) mice. As shown in Figure 6 (panels A, C), at variance with PS2-NI mice, PS2KO mice 273 
showed the same power levels of wt mice in the SG and FG ranges. Similarly, APPSwe mice, in the absence 274 
of mutant PS2, lacked the power increase in the Beta-Gamma range that characterized the PS2APP mice, 275 
while preserving the increased spectral steepness (Fig. 6B-D). Of note, at 6 months, these latter mice did 276 
not show plaques (Richards et al., 2003), yet they display intraneuronal APP/Aβ accumulation with a 277 
distribution similar to that reported for 3 month-old PS2APP mice (Supplementary Fig. 7). No power 278 
Table 1. Summary of the electrophysiological alterations in the tg mouse lines in comparison with wt mice. 
 3 months  6 months  12 months 
 PS2-NI PS2APP  PS2-NI PS2APP PS2KO APPSwe  PS2-NI PS2APP 
Beta power - -  - ↑↑ - -  - - 
SG power - -  ↑ ↑↑ - -  - - 
FG power - -  ↑ - - -  - - 
Theta-beta PAC - -  - ↑ - -  - - 
Theta-SG PAC - -  - ↑ - -  - - 
Theta-Epsilon 
PAC 
- -  - - - -  - ↓↓ 
PSD steepness - ↑↑↑↑  - ↑↑ - ↑↑  - - 
PSD offset - ↑  - ↑↑↑↑ - -  - - 
           
↑, p < 0.05; ↑↑, p < 0.01; ↑↑↑↑, p < 0.0001; ↓, p < 0.05; Mann-Whitney test 
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difference was found in the other frequency bands for both PS2KO and APPSwe mice as well as in PAC and 279 
PSD offset, that resulted statistically unaltered (Supplementary Fig. 8A-H). 280 
Taken together, the results, summarized in Table 1, indicate that the PS2APP mice express markedly 281 
different alterations of network activity in terms of Theta-Gamma frequency coupling at 3 and 6 months of 282 
age. In particular, at 6 months of age, these mice displayed significant over-coupling in two of the 283 
considered classes, as opposite to the other tg mice that reported no alteration in any class. Finally, hyper-284 
synchronicity, as revealed by greater power steepness, characterized the early stages of PS2APP, appearing 285 
as early as 3 months and progressively declining with aging. 286 
3.6 HIPPOCAMPAL APP PROCESSING  287 
The hippocampi from 6-month-old APPSwe mice were also used to estimate the absolute amount of total 288 
Aβ40 and Aβ42, compared to PS2APP mice (see Supplementary Table 1). Upon ELISA (Millipore), we could 289 
estimate that APPSwe mice had 10 and 100 times less Aβ40 and Aβ42 respectively (Aβ42/Aβ40 ratio: PS2APP, 290 
0.8; APPSwe, 0.2) while in PS2KO and PS2-NI mice Aβ was undetectable. Of note, the absolute amount of 291 
Aβ42 in 6-month-old APPSwe mice approximated that of 3-month-old PS2APP mice ( ~ 100 pg/mg wet 292 
tissue). The hippocampal levels of both mouse and human full-length APP (fl-APP), as well as those of its 293 
carboxy-terminal fragments (CTFs), were analyzed by Western blotting at 6 months of age (Supplementary 294 
Methods). Both APPSwe and PS2APP mice showed large, comparable amounts of human APP 295 
(Supplementary Fig. 9A, B). The former mouse line, however, displayed much higher levels of CTFs 296 
(Supplementary Fig. 9B), as previously reported (Poirier et al., 2010). Finally, because of the mutant PS2 297 
expression, PS2APP but not APPSwe mice had higher levels of the amyloid intracellular domain (AICD) and 298 
Aβ (Supplementary Fig. 9B). Of note, PS2-NI and PS2KO mice had mAPP levels similar to those of wt mice, 299 
however higher amounts of CTFs (Supplementary Fig. 9A, B).  300 
4 DISCUSSION 301 
This work was aimed at detecting, at the in vivo level, early alterations of spontaneous electrical activity in 302 
the homozygous PS2APP mouse model (B6.152H line), based on the two FAD-linked mutations, PS2-NI and 303 
APP Swedish (Ozmen et al., 2009). The rationale of our approach was based on the following 304 
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considerations: i) the urgency to discover early biomarkers of AD brain dysfunctions, well before the onset 305 
of amyloid deposition and the appearance of cognitive deficits, a need that is critical for both AD patient 306 
and mouse model studies; ii) the recent discovery that different PS2 mutants, including PS2-NI, exert a 307 
primary role in Ca
2+
 dyshomeostasis by causing reduced store Ca
2+
 content and increased ER-mitochondria 308 
coupling (Zampese et al., 2011a, Zampese et al., 2011b), and finally iii) the demonstration that PS2-based 309 
AD mouse models show significant early increase in neuronal Ca
2+
 excitability, at both the in vitro and the in 310 
situ level (Kipanyula et al., 2012). The latter finding thus offers the opportunity to test the “Ca
2+
 hypothesis 311 
of AD” in vivo, in the absence or presence of Aβ accumulation and gliosis.  312 
To address our aim, we carried out in vivo LFP recordings from the two homozygous mouse lines, PS2-NI 313 
and PS2APP, as well from the prevalent background strain, the C57BL/6J (wt) mice. We acquired the LFP 314 
signal in the DG - one of the earliest affected regions - under urethane anesthesia and extracted signal 315 
features including amplitude, spectral steepness and Theta-higher frequency PAC by means of time-316 
frequency methods. Importantly, to the end of assessing the temporal evolution of the features into exam, 317 
we investigated 3, 6 and 12 month-old female mice, i.e. before, during and after plaque deposition, and we 318 
probed the time-matched presence of histological hallmarks, in the form of amyloid plaques and 319 
astrogliosis, as well as the degree of Aβ load. As summarized in Table 1, different electrophysiological 320 
parameters were significantly altered in the two mouse lines with respect to wt mice. The physiological 321 
significance of the alterations observed in the power, PAC and steepness categories are here briefly 322 
summarized and discussed in the context of the AD neuropathology.  323 
Similar to EEG, also LFP signals, when converted in the frequency domain by means of the Fourier 324 
transform, display a characteristic composition of a broad range of frequencies where, importantly, the 325 
amplitude exponentially decays as a function of the frequency. In agreement, the PSD function of a brain 326 
extracellular recording is often defined as 1/f
x
, where x is the scaling exponential of the decay (He et al., 327 
2010). Recently, the 1/f
x
 function has been led down to the size of the various frequency generators 328 
(Logothetis et al., 2007) and has started to be widely recognized as a large scale representation of neural 329 
activity, thus, as a rich source of valuable information on the underlying network operations (Buzsáki et al., 330 
2013, He et al., 2010, He, 2014). 331 
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Whereas the broad band power of extracellular brain recordings was shown to positively correlate with 332 
neuronal firing rate (Manning et al., 2009), the slope coefficient of the PSD function is a measure of 333 
neuronal firing synchronicity. In particular, a decrease in spectral steepness points to an enhancement of 334 
decoupled firing, whereas an increase in steepness indicates enhanced synchronicity (Freeman and Zhai, 335 
2009, Podvalny et al., 2015, Voytek and Knight, 2015). In humans, aging was associated with 336 
desynchronized neural spiking activity, as measured by extracellular recordings and reflected by flatter 337 
power spectra in the semi-log space (Voytek et al., 2015).   338 
Because PSD log-log plots, derived from LFP recordings in the DG, showed a corner frequency in the 339 
Gamma range we used the above mentioned approach to evaluate the level of synchronicity of the 340 
hippocampal  network: PSD functions were thus plotted in the semi-log space and the slope coefficients 341 
were measured in the 10 – 100 Hz range, following robust linear fit (Voytek et al., 2015).  An early increase 342 
of PSD steepness was already apparent at 3-months of age in PS2APP mice with respect to wt; the 343 
phenomenon persisted at 6 months, whereas a progressive reduction of its degree was observed at 12 344 
months of age
§
. Following linear fitting, an increase in population spiking activity is also reflected by offset 345 
increase (Voytek and Knight, 2015). When compared to wt, at 3 months, PS2APP mice displayed a three 346 
times greater offset, which persisted high at 6 months of age; the offset of PS2-NI mice was not changed, 347 
however its decline was delayed. 348 
Another notable feature of brain extracellular recordings is embodied by nested oscillations, where a 349 
slower rhythm influences a faster one in a dynamic fashion. In the last decade, this latter type of phase-350 
amplitude CFC, known as PAC, has drawn much attention, in particular concerning the Theta and Gamma 351 
oscillations. Theta-Gamma PAC has consistently been described in several brain regions, including the 352 
cortex (Canolty et al., 2006, Lee et al., 2005) and the hippocampus (Axmacher et al., 2010, Belluscio et al., 353 
2012, Bragin et al., 1995) and it was functionally linked to memory performance (Shirvalkar et al., 2010). 354 
Few results are available so far describing CFC in AD mouse models, at the in vivo level (Gurevicius et al., 355 
2013, Ittner et al., 2014, Stoiljkovic et al., 2016). 356 
                                                          
§
 By linear fitting of PSD log-log plots in the range 30 - 100 Hz, we obtained very similar statistical 
differences between PS2APP and wt mice, at 3 and 6 months of age (data not shown). 
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We investigated the level of CFC existing in our LFP signals between the Theta phase and the amplitude of 357 
Beta, SG, FG and Epsilon band, respectively, as quantified by the GLM index. This particular feature of brain 358 
network activity is regarded as a bridge between local microscale neuronal ensembles and the systems-359 
level macroscale network, allowing for dynamic network communication through a phase-coding 360 
mechanism (Voytek and Knight, 2015, Watrous et al., 2015). 361 
When compared to wt, at 6 months of age, PS2APP mice displayed enhanced PAC in the Theta-Beta and -SG 362 
classes. These observations indicate a condition of over-coupling in the PS2APP line with respect to wt 363 
mice. Of note, a modest increase in Theta-Gamma coupling was also observed in 4-month-old 364 
APPSwe/PS1dE9 mice (Gurevicius et al., 2013), whereas in APP23 mice a reduction in Theta-Gamma 365 
coupling was reported (Ittner et al., 2014). In the PS2-NI line, PAC resulted unaffected with respect to wt 366 
mice in all classes, at both 3 and 6 months of age, with the two tg mouse lines reporting the strongest 367 
difference. Curiously, at 12 months of age, the observed changes in PAC were not maintained, however a 368 
decrease in Theta-Epsilon PAC was noticeable in PS2APP mice when compared to the other lines, a 369 
phenomenon that might represent the beginning of a different disease stage. A similar decrease in Theta-370 
Gamma CFC was found in 4-month-old APP23 mice  (Ittner et al., 2014). 371 
While both the PAC and the PSD steepness are referred to as indicators of synchronicity within the 372 
network, their alterations in the PS2APP line did not overlap. It is important to note that they are not 373 
believed to represent the same phenomenon. On the one hand, PAC describes the level of modulation that 374 
the phase of a carrier frequency exerts on the amplitude of a faster one, in other words, it represents the 375 
ability of the slower rhythm to affect the statistical temporal distribution of neuronal firing. Conversely, the 376 
PSD steepness reflects the overall statistics of neuronal firing, with a steeper slope resulting from a shift of 377 
neuronal firing towards increased synchronicity, thus contributing to the power of the slower oscillations 378 
(Podvalny et al., 2015). From statistical analysis, the Theta-SG PAC significantly correlated with Theta but 379 
not Gamma power in all mouse lines, whereas a correlation between PAC and steepness was found only in 380 
PS2APP mice. 381 
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In conclusion, PSD steepness and Theta-Gamma frequency PAC are features of the hippocampal LFP signals 382 
that reliably characterize the earliest stage of the AD-like pathology in the PS2APP mouse model, and, 383 
limited to increased steepness, also the APPSwe model. 384 
Power quantification within different frequency bands is a widely used approach. However, the 385 
physiological significance of power-content changes in a given band should be carefully addressed. The 386 
power of individual bands is estimated basing on the frequency-domain representation of the signal, i.e. 387 
the PSD function. As a matter of fact, the brain PSD is a combination of oscillatory as well as irregular 388 
activities and, as such, it is a complex and, unfortunately, poorly understood phenomenon (He, 2014). 389 
Nevertheless, general consensus advocates that while real oscillations determine narrow-band peaks in the 390 
PSD, broad-band “bulges” represent the spectral counterpart of neuronal firing. 391 
In the present study, we observed an alteration of the PSD function in the PS2-NI and PS2APP models that 392 
occurs as a shoulder of increased power in the spectrum encompassing the Beta range in 3-month-old 393 
PS2APP mice and, respectively, the Beta-SG and the SG-FG range in the PS2APP and PS2-NI mice, at 6 394 
months of age. The phenomenon likely reflects an increase of neuronal firing with respect to wt mice, i.e. 395 
hyper-activity, that also results in a marked increase in power offset, especially in PS2APP mice. 396 
All in all, the here reported alterations of power spectra suggest that PS2-NI and PS2APP mouse models 397 
present a clear condition of neuronal hyper-activity at 6 months of age. Since no hyper-activity was found 398 
at the same age in PS2KO and APPSwe mice, this feature can be regarded as a gain-of-function brought 399 
about by the mutant PS2, possibly through alterations in store Ca
2+
 handling.  400 
It remains to be established whether mutant PS2, as a cell Ca
2+
 disorganizer, exerts its effect primarily at 401 
the level of neurons or astrocytes, considered that its expression is under the prion protein promoter and 402 
the fact that astrocytes are directly involved in neuronal synchrony (Chever et al., 2016, Fellin et al., 2004, 403 
Pabst et al., 2016). While in PS2-NI mice the Aβ42 level is very low, it is conceivable that in PS2APP mice, 404 
accumulation of Aβ42 oligomers further contributes to hyper-activity by reducing the excitatory neuronal 405 
threshold (Busche et al., 2012, Minkeviciene et al., 2009) as well as by worsening Ca
2+
 handling (Agostini 406 
and Fasolato, 2016, Lazzari et al., 2015).  407 
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The phenomena of hyper-activity and hyper-synchronicity are both well-known in the clinical field of AD. 408 
Many works have investigated brain activity alterations in patients diagnosed with AD or MCI by means of 409 
functional imaging techniques, the most popular being the fMRI. Overall, these studies contributed to draw 410 
a picture where the beginning of the clinical phase of AD, corresponding to MCI, is marked by hyper-activity 411 
in the hippocampus as well as other cortical regions, that disappears with overt AD (Dickerson et al., 2005, 412 
Hämäläinen et al., 2007, Pihlajamaki et al., 2009). Interestingly, the here reported hippocampal hyper-413 
activity is lost at 12 months of age while, in PS2APP mice, it was shown that defects in hippocampal 414 
working memory are present at 8 months, disappear at 12, and finally precipitate between 16 and 20 415 
months (Woolley and Ballard, 2005).  416 
Hyper-synchronicity, on the other hand, represents a common feature in AD, often in the form of silent 417 
seizures. The incidence of seizures is higher in AD patients than in control groups (Lozsadi and Larner, 2006) 418 
and it reaches even higher levels in the early-onset FAD subjects (Palop and Mucke, 2009) with 32% of PS2-419 
N141I-FAD patients showing seizures (Jayadev et al., 2010). Notably, epileptic events have been often 420 
observed as electroencephalographic seizures associated with transient epileptic amnesia (TEA) 421 
(Rabinowicz et al., 2000), raising the hypothesis of epileptic discharge to be an underestimated 422 
phenomenon (Mendes, 2002, Palop et al., 2007).  423 
Taken together, the above described findings provide a framework for the interpretation of our results in 424 
regard to both hyper-excitability and hyper-synchronicity. The former, that we statistically detect in both 425 
PS2-NI and PS2APP lines at 6 months of age, is in line with previous studies indicating a condition of 426 
enhanced fMRI activity in MCI patients, while the latter correlates with higher incidence of epilepsy found 427 
in FAD families’ pedigrees, as well as with the consistent observation of TEA in AD patients. 428 
The neuronal hyper-activity, found in both the above mentioned tg lines, adds to similar previous 429 
observations obtained from other AD mouse models, in support to the hypothesis claiming early neuronal 430 
hyper-activity to be a biomarker of AD. In particular, neuronal hyper-excitability was demonstrated in 431 
mouse models expressing human FAD-linked APP mutations alone or together with different PS1 mutations 432 
and it was linked to the appearance of non-convulsive seizures (Palop et al., 2007). Epileptic activity has 433 
been consistently found in APPJ20 (Palop et al., 2007), APP23 (Ittner et al., 2014), Tg2576 (Westmark et al., 434 
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2008) and CRND8 mice (Del Vecchio et al., 2004). In particular, not only sporadic seizures were described to 435 
spontaneously appear in freely behaving animals (Ittner et al., 2014, Palop et al., 2007, Westmark et al., 436 
2008) but, in addition, hyper-synchronicity emerged as an enhanced tendency to the development of 437 
seizures after administration of riluzole (Ittner et al., 2014, Verret et al., 2012), a voltage gated sodium 438 
channel blocker, or pentylenetetrazol (Del Vecchio et al., 2004, Westmark et al., 2008), a GABA-A receptor 439 
antagonist. 440 
Hyper-activity, in terms of increased neuronal firing rate, was reported in 4- to 7-month-old APPJ20 mice 441 
under basal conditions, just before plaque deposition (Verret et al., 2012). Higher seizure susceptibility and 442 
hyper-synchrony were reported in Tg2576 mice as early as 1.5 months (Bezzina et al., 2015), as well as in 443 
APPSwe/PS1dE9, a line that, for some  features, resembles the PS2APP line: i.e. similar Aβ42, Aβ40 levels and 444 
ratio (Gurevicius et al., 2013, Minkeviciene et al., 2009, Sierksma et al., 2013) and, possibly, also store Ca
2+
 445 
deficit (Honarnejad et al., 2013), but differs for the larger and wider expression of hAPPSwe, being also this 446 
latter under the prion protein promoter. 447 
Furthermore, neuronal hyper-activity, as augmented rate of Ca
2+
 transients, was observed in the cortex of 448 
6-month-old mice from the APP23xPS45 line (Busche et al., 2008), and was later reported to occur in the 449 
hippocampus as well, at the age of 1-2 months, before plaque deposition (Busche et al., 2012). Close to our 450 
study, enhancement of hippocampal Gamma power in the range ∼ 20-45 Hz was reported in freely 451 
behaving 4-month-old APP23 mice (Ittner et al., 2014), characterized by plaque deposition starting at 6 452 
months of age (Sturchler-Pierrat et al., 1997). 453 
To address the question of what, among Ca
2+
 hyper-activity, APP overexpression, or Aβ accumulation, is the 454 
major responsible of the observed phenomena, we compared PS2APP mice with the mouse lines carrying 455 
the single mutations. Interestingly, PS2APP mice develop a condition of hippocampal hyper-activity at the 456 
same age of PS2-NI mice. This occurs despite the drastically different levels of Aβ production. In particular, 457 
at 6 months, when we found increased SG-FG power, PS2-NI mice present neither plaque deposition nor 458 
significant signs of astrogliosis, with Aβ42 levels not significantly higher than those found in age-matched wt 459 
mice. Thus, hyper-activity in the Gamma band does not seem to correlate with Aβ42 levels and, considering 460 
the mismatch with plaques and astrogliosis in PS2-NI mice, it is not due to a compensatory mechanism 461 
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(Stargardt et al., 2015). Finally, this type of hyper-activity was absent in 6-month-old PS2KO and APPSwe 462 
mice, despite these latter reach Aβ42 levels in the range of the 3-month-old PS2APP mice. Altogether these 463 
findings reinforce the idea that hyper-activity likely represents a gain-of-function, due to the mutant PS2. 464 
Nevertheless, when compared to PS2-NI, PS2APP mice exhibit a pattern of alterations of the LFP activity 465 
that is more complex. Indeed, in conjunction with the hyper-activity, they also present hyper-synchronicity, 466 
detectable as early as 3 months of age in the form of a steeper PSD function decay, and, at 6 months of age, 467 
as an enhanced Theta-Beta and Theta-SG PAC. Since hyper-synchronicity is not detectable in the PS2-NI line 468 
at any age, this aspect was possibly attributable to the much higher levels of soluble Aβ. Experiments on 6-469 
month-old APPSwe mice confirmed the presence of hyper-synchronicity, however in the absence of PAC 470 
alterations, i.e. a condition similar to that found in 3-month-old PS2APP. These findings indicate that an 471 
increase in power steepness is required but not sufficient to observe Theta-SG PAC and support the 472 
hypothesis of an enhanced neuronal activity, in the form of hyper-synchronicity, preceding the first histo-473 
pathological and clinical symptoms (Stargardt et al., 2015). The observed phenomena are consistent with 474 
the sharp wave discharge found in Tet-Off APP mice, a type of hyper-synchronization that could be rescued 475 
by APP suppression (Born et al., 2014). Whether the here described hyper-synchronicity is due to fl-APP or 476 
one of its products has to be tested yet. Indeed, with respect to APPSwe, PS2APP mice show almost similar 477 
levels of fl-APP albeit a much larger amount of CTFs and AICD, thus, accumulation of these latter might play 478 
the major role. It is worth noting that disruption of Theta-FG CFC was observed in hippocampus, but not 479 
prefrontal cortex, of APP-KO mice, in the absence of specific effects on oscillation power (Zhang et al., 480 
2016), thus suggesting that endogenous APP plays a direct role on regional coupling mechanisms. Finally, 481 
the increase in PAC, which we observed only in 6-month-old PS2APP mice, well correlates with the rising 482 
phase of Aβ42 accumulation and gliosis. 483 
It is worth mentioning that hyper-activity at the DG level has been connected to reduced neurogenesis 484 
given that DG interneurons seem to be more effectively driven by young adult-born neurons (Lacefield et 485 
al., 2012). Of note, the PS2APP mice are characterized by reduced neurogenesis at the DG level as early as 4 486 
months of age (Poirier et al., 2010, Richards et al., 2003). 487 
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Because homozygous tg mice were used in this study, we cannot entirely exclude that genetic drift might 488 
have occurred in our colonies, however we can reasonably rule out that, the two principal features, i.e. the 489 
increase in the broad band Gamma power and the increase in steepness were due to genetic drift. In fact, it 490 
is highly unlikely that they similarly occurred in two different tg lines, the PS2-NI and PS2APP mice, from 491 
one side, and the PS2APP and APPSwe mice, from the other. 492 
Although many studies have pointed to an increased spiking synchronicity as a common feature of mouse 493 
lines expressing mutated forms of APP, to the best of our knowledge, no previous report with AD mouse 494 
models addressed neuronal synchronicity by means of the PSD steepness. By means of this tool, we were 495 
able to distinguish the specific contribution of mutant PS2 and APP to early hippocampal network 496 
dysfunctions. 497 
5 CONCLUSIONS 498 
In the DG of PS2APP mice, we report three major patterns of early electrophysiological alterations: i) 499 
increased power in the Beta/Gamma frequency bands; ii) increased power steepness; iii) increased PAC in 500 
the Theta-Beta and Theta-SG bands. The first two findings can be attributed to the expression of mutant 501 
PS2 and APP, respectively. Only the appearance of increased PAC uniquely characterizes the PS2APP mice 502 
at 6 months of age when plaques and gliosis start to appear.  503 
6 ACKNOWLEDGEMENTS 504 
We are grateful to L. Ozmen and F. Hoffmann-La Roche Ltd (Basel, Switzerland) for kindly donating the 505 
PS2APP and APPSwe mice, to T. Pozzan and P. Magalhaes for support and critical reading the manuscript. 506 
This work was supported by the Italian Ministry of University and Scientific Research and the University of 507 
Padua (FASO-PRAT16-01 to CF); FINA grant to SV; the Strategic Projects of the University of Padua and the 508 
Italian National Research Council, CNR (Ageing project to TP); RF, MR and MA were supported by a Ph.D. 509 
fellowship from the University of Padua. ES was a graduate student of the University of Padua, RF and EM 510 
and MM, as post-docs, were supported by FINA grant to SV. We declare no competing financial interests.  511 
Author statement: CF, RF and SV planned and designed the work; RF and CF wrote the manuscript; RF and 512 
EM (partial contribution) executed the electrophysiological experiments; MM, RF, MR and GS performed 513 
analyses on electrophysiological data; MA and ES executed the histology and the biochemical experiments. 514 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
 
 22
7 DISCLOSURE STATEMENT 515 
The authors declare no conflicts of interest. 516 
  517 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
 
 23
8 REFERENCES 518 
Agostini, M., Fasolato, C., 2016. When, where and how? Focus on neuronal calcium dysfunctions 519 
in Alzheimer’s Disease. Cell Calcium. 520 
Axmacher, N., Henseler, M.M., Jensen, O., Weinreich, I., Elger, C.E., Fell, J., 2010. Cross-521 
frequency coupling supports multi-item working memory in the human hippocampus. 522 
Proc.Natl.Acad.Sci.U.S.A. 107, 3228-3233. 523 
Belluscio, M.A., Mizuseki, K., Schmidt, R., Kempter, R., Buzsaki, G., 2012. Cross-frequency 524 
phase-phase coupling between theta and gamma oscillations in the hippocampus. J.Neurosci. 32, 525 
423-435. 526 
Bezzina, C., Verret, L., Juan, C., Remaud, J., Halley, H., Rampon, C., Dahan, L., 2015. Early onset 527 
of hypersynchronous network activity and expression of a marker of chronic seizures in the Tg2576 528 
mouse model of Alzheimer’s disease. 10, e0119910. 529 
Bhat, S., Acharya, U.R., Dadmehr, N., Adeli, H., 2015. Clinical Neurophysiological and Automated 530 
EEG-Based Diagnosis of the Alzheimer's Disease. Eur.Neurol. 74, 202-210. 531 
Born, H.A., Kim, J.Y., Savjani, R.R., Das, P., Dabaghian, Y.A., Guo, Q., Yoo, J.W., Schuler, D.R., 532 
Cirrito, J.R., Zheng, H., Golde, T.E., Noebels, J.L., Jankowsky, J.L., 2014. Genetic suppression of 533 
transgenic APP rescues Hypersynchronous network activity in a mouse model of Alzeimer's 534 
disease. J.Neurosci. 34, 3826-3840. 535 
Bragin, A., Jando, G., Nadasdy, Z., Hetke, J., Wise, K., Buzsaki, G., 1995. Gamma (40-100 Hz) 536 
oscillation in the hippocampus of the behaving rat. J.Neurosci. 15, 47-60. 537 
Busche, M.A., Grienberger, C., Keskin, A.D., Song, B., Neumann, U., Staufenbiel, M., Förstl, H., 538 
Konnerth, A., 2015. Decreased amyloid-[beta] and increased neuronal hyperactivity by 539 
immunotherapy in Alzheimer's models. Nat.Neurosci. 540 
Busche, M.A., Chen, X., Henning, H.A., Reichwald, J., Staufenbiel, M., Sakmann, B., Konnerth, 541 
A., 2012. Critical role of soluble amyloid-beta for early hippocampal hyperactivity in a mouse 542 
model of Alzheimer's disease. Proc.Natl.Acad.Sci.U.S.A. 109, 8740-8745. 543 
Busche, M.A., Eichhoff, G., Adelsberger, H., Abramowski, D., Wiederhold, K.H., Haass, C., 544 
Staufenbiel, M., Konnerth, A., Garaschuk, O., 2008. Clusters of hyperactive neurons near amyloid 545 
plaques in a mouse model of Alzheimer's disease. Science. 321, 1686-1689. 546 
Buzsáki, G., Logothetis, N., Singer, W., 2013. Scaling brain size, keeping timing: evolutionary 547 
preservation of brain rhythms. Neuron. 80, 751-764. 548 
Camandola, S., Mattson, M.P., 2011. Aberrant subcellular neuronal calcium regulation in aging and 549 
Alzheimer's disease. 1813, 965-973. 550 
Canolty, R.T., Edwards, E., Dalal, S.S., Soltani, M., Nagarajan, S.S., Kirsch, H.E., Berger, M.S., 551 
Barbaro, N.M., Knight, R.T., 2006. High gamma power is phase-locked to theta oscillations in 552 
human neocortex. Science. 313, 1626-1628. 553 
Chever, O., Dossi, E., Pannasch, U., Derangeon, M., Rouach, N., 2016. Astroglial networks 554 
promote neuronal coordination. Sci.Signal. 9, ra6. 555 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
 
 24
Decuypere, J., Bultynck, G., Parys, J.B., 2011. A dual role for Ca 2 in autophagy regulation. Cell 556 
Calcium. 50, 242-250. 557 
Del Vecchio, R.A., Gold, L.H., Novick, S.J., Wong, G., Hyde, L.A., 2004. Increased seizure 558 
threshold and severity in young transgenic CRND8 mice. Neurosci.Lett. 367, 164-167. 559 
Dickerson, B.C., Salat, D.H., Greve, D.N., Chua, E.F., Rand-Giovannetti, E., Rentz, D.M., Bertram, 560 
L., Mullin, K., Tanzi, R.E., Blacker, D., Albert, M.S., Sperling, R.A., 2005. Increased hippocampal 561 
activation in mild cognitive impairment compared to normal aging and AD. Neurology. 65, 404-562 
411. 563 
Fellin, T., Pascual, O., Gobbo, S., Pozzan, T., Haydon, P.G., Carmignoto, G., 2004. Neuronal 564 
synchrony mediated by astrocytic glutamate through activation of extrasynaptic NMDA receptors. 565 
Neuron. 43, 729-743. 566 
Freeman, W.J., Zhai, J., 2009. Simulated power spectral density (PSD) of background 567 
electrocorticogram (ECoG). 3, 97-103. 568 
Giacomello, M., Barbiero, L., Zatti, G., Squitti, R., Binetti, G., Pozzan, T., Fasolato, C., Ghidoni, 569 
R., Pizzo, P., 2005. Reduction of Ca 2 stores and capacitative Ca 2 entry is associated with the 570 
familial Alzheimer's disease presenilin-2 T122R mutation and anticipates the onset of dementia. 571 
Neurobiol.Dis. 18, 638-648. 572 
Golde, T.E., Schneider, L.S., Koo, E.H., 2011. Anti-aβ therapeutics in Alzheimer's disease: the need 573 
for a paradigm shift. Neuron. 69, 203-213. 574 
Gurevicius, K., Lipponen, A., Tanila, H., 2013. Increased cortical and thalamic excitability in freely 575 
moving APPswe/PS1dE9 mice modeling epileptic activity associated with Alzheimer's disease. 576 
Cereb.Cortex. 23, 1148-1158. 577 
Hämäläinen, A., Pihlajamäki, M., Tanila, H., Hänninen, T., Niskanen, E., Tervo, S., Karjalainen, 578 
P.A., Vanninen, R.L., Soininen, H., 2007. Increased fMRI responses during encoding in mild 579 
cognitive impairment. Neurobiol.Aging. 28, 1889-1903. 580 
He, B.J., 2014. Scale-free brain activity: past, present, and future. Trends Cogn.Sci.(Regul.Ed.). 18, 581 
480-487. 582 
He, B.J., Zempel, J.M., Snyder, A.Z., Raichle, M.E., 2010. The temporal structures and functional 583 
significance of scale-free brain activity. Neuron. 66, 353-369. 584 
Herreman, A., Hartmann, D., Annaert, W., Saftig, P., Craessaerts, K., Serneels, L., Umans, L., 585 
Schrijvers, V., Checler, F., Vanderstichele, H., Baekelandt, V., Dressel, R., Cupers, P., 586 
Huylebroeck, D., Zwijsen, A., Van Leuven, F., De Strooper, B., 1999. Presenilin 2 deficiency 587 
causes a mild pulmonary phenotype and no changes in amyloid precursor protein processing but 588 
enhances the embryonic lethal phenotype of presenilin 1 deficiency. Proc.Natl.Acad.Sci.U.S.A. 96, 589 
11872-11877. 590 
Honarnejad, K., Jung, C.K., Lammich, S., Arzberger, T., Kretzschmar, H., Herms, J., 2013. 591 
Involvement of presenilin holoprotein upregulation in calcium dyshomeostasis of Alzheimer's 592 
disease. J.Cell.Mol.Med. 17, 293-302. 593 
Huang, Y., Yang, S., Hu, Z., Liu, G., Zhou, W., Zhang, Y., 2012. A new approach to location of the 594 
dentate gyrus and perforant path in rats/mice by landmarks on the skull. 72, 468-472. 595 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
 
 25
Ittner, A.A., Gladbach, A., Bertz, J., Suh, L.S., Ittner, L.M., 2014. p38 MAP kinase-mediated 596 
NMDA receptor-dependent suppression of hippocampal hypersynchronicity in a mouse model of 597 
Alzheimer’s disease. 2, 1-17. 598 
Jayadev, S., Leverenz, J.B., Steinbart, E., Stahl, J., Klunk, W., Yu, C.E., Bird, T.D., 2010. 599 
Alzheimer's disease phenotypes and genotypes associated with mutations in presenilin 2. Brain. 600 
133, 1143-1154. 601 
Khan, U.A., Liu, L., Provenzano, F.A., Berman, D.E., Profaci, C.P., Sloan, R., Mayeux, R., Duff, 602 
K.E., Small, S.A., 2014. Molecular drivers and cortical spread of lateral entorhinal cortex 603 
dysfunction in preclinical Alzheimer's disease. Nat.Neurosci. 17, 304-311. 604 
Kipanyula, M.J., Contreras, L., Zampese, E., Lazzari, C., Wong, A.K., Pizzo, P., Fasolato, C., 605 
Pozzan, T., 2012. Ca2 dysregulation in neurons from transgenic mice expressing mutant presenilin 606 
2. 11, 885-893. 607 
Lacefield, C.O., Itskov, V., Reardon, T., Hen, R., Gordon, J.A., 2012. Effects of adult‐generated 608 
granule cells on coordinated network activity in the dentate gyrus. Hippocampus. 22, 106-116. 609 
Lazzari, C., Kipanyula, M.J., Agostini, M., Pozzan, T., Fasolato, C., 2015. Aβ42 oligomers 610 
selectively disrupt neuronal calcium release. Neurobiol.Aging. 36, 877-885. 611 
Lee, H., Simpson, G.V., Logothetis, N.K., Rainer, G., 2005. Phase locking of single neuron activity 612 
to theta oscillations during working memory in monkey extrastriate visual cortex. Neuron. 45, 147-613 
156. 614 
Logothetis, N.K., Kayser, C., Oeltermann, A., 2007. In vivo measurement of cortical impedance 615 
spectrum in monkeys: implications for signal propagation. Neuron. 55, 809-823. 616 
Lord, A., Kalimo, H., Eckman, C., Zhang, X., Lannfelt, L., Nilsson, L.N., 2006. The Arctic 617 
Alzheimer mutation facilitates early intraneuronal Aβ aggregation and senile plaque formation in 618 
transgenic mice. Neurobiol.Aging. 27, 67-77. 619 
Lozsadi, D.A., Larner, A.J., 2006. Prevalence and causes of seizures at the time of diagnosis of 620 
probable Alzheimer's disease. Dement.Geriatr.Cogn.Disord. 22, 121-124. 621 
Manning, J.R., Jacobs, J., Fried, I., Kahana, M.J., 2009. Broadband shifts in local field potential 622 
power spectra are correlated with single-neuron spiking in humans. J.Neurosci. 29, 13613-13620. 623 
Mendes, M.H.F., 2002. Transient epileptic amnesia: an under-diagnosed phenomenon? Three more 624 
cases. Seizure. 11, 238-242. 625 
Minkeviciene, R., Rheims, S., Dobszay, M.B., Zilberter, M., Hartikainen, J., Fulop, L., Penke, B., 626 
Zilberter, Y., Harkany, T., Pitkanen, A., Tanila, H., 2009. Amyloid beta-induced neuronal 627 
hyperexcitability triggers progressive epilepsy. J.Neurosci. 29, 3453-3462. 628 
Mitchell, A.J., Monge-Argiles, J.A., Sanchez-Paya, J., 2010. Do CSF biomarkers help clinicians 629 
predict the progression of mild cognitive impairment to dementia?. Pract.Neurol. 10, 202-207. 630 
Namgung, U., Valcourt, E., Routtenberg, A., 1995. Long-term potentiation in vivo in the intact 631 
mouse hippocampus. Brain Res. 689, 85-92. 632 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
 
 26
Ozmen, L., Albientz, A., Czech, C., Jacobsen, H., 2009. Expression of transgenic APP mRNA is 633 
the key determinant for beta-amyloid deposition in PS2APP transgenic mice. Neurodegener Dis. 6, 634 
29-36. 635 
Pabst, M., Braganza, O., Dannenberg, H., Hu, W., Pothmann, L., Rosen, J., Mody, I., van Loo, K., 636 
Deisseroth, K., Becker, A.J., 2016. Astrocyte Intermediaries of Septal Cholinergic Modulation in 637 
the Hippocampus. Neuron. 90, 853-865. 638 
Palop, J.J., Chin, J., Roberson, E.D., Wang, J., Thwin, M.T., Bien-Ly, N., Yoo, J., Ho, K.O., Yu, 639 
G., Kreitzer, A., 2007. Aberrant excitatory neuronal activity and compensatory remodeling of 640 
inhibitory hippocampal circuits in mouse models of Alzheimer's disease. Neuron. 55, 697-711. 641 
Palop, J.J., Mucke, L., 2009. Epilepsy and cognitive impairments in Alzheimer disease. 642 
Arch.Neurol. 66, 435-440. 643 
Penny, W., Duzel, E., Miller, K., Ojemann, J., 2008. Testing for nested oscillation. 644 
J.Neurosci.Methods. 174, 50-61. 645 
Pihlajamaki, M., Jauhiainen, A.M., Soininen, H., 2009. Structural and functional MRI in mild 646 
cognitive impairment. 6, 179-185. 647 
Podvalny, E., Noy, N., Harel, M., Bickel, S., Chechik, G., Schroeder, C.E., Mehta, A.D., Tsodyks, 648 
M., Malach, R., 2015. A unifying principle underlying the extracellular field potential spectral 649 
responses in the human cortex. J.Neurophysiol., jn. 00943.2014. 650 
Poirier, R., Veltman, I., Pflimlin, M.C., Knoflach, F., Metzger, F., 2010. Enhanced dentate gyrus 651 
synaptic plasticity but reduced neurogenesis in a mouse model of amyloidosis. Neurobiol.Dis. 40, 652 
386-393. 653 
Prendergast, B.J., Onishi, K.G., Zucker, I., 2014. Female mice liberated for inclusion in 654 
neuroscience and biomedical research. 40, 1-5. 655 
Rabinowicz, A.L., Starkstein, S.E., Leiguarda, R.C., Coleman, A.E., 2000. Transient epileptic 656 
amnesia in dementia: a treatable unrecognized cause of episodic amnestic wandering. 14, 231-233. 657 
Richards, J.G., Higgins, G.A., Ouagazzal, A.M., Ozmen, L., Kew, J.N., Bohrmann, B., Malherbe, 658 
P., Brockhaus, M., Loetscher, H., Czech, C., Huber, G., Bluethmann, H., Jacobsen, H., Kemp, J.A., 659 
2003. PS2APP transgenic mice, coexpressing hPS2mut and hAPPswe, show age-related cognitive 660 
deficits associated with discrete brain amyloid deposition and inflammation. J.Neurosci. 23, 8989-661 
9003. 662 
Shirvalkar, P.R., Rapp, P.R., Shapiro, M.L., 2010. Bidirectional changes to hippocampal theta-663 
gamma comodulation predict memory for recent spatial episodes. Proc.Natl.Acad.Sci.U.S.A. 107, 664 
7054-7059. 665 
Sierksma, A.S., Rutten, K., Sydlik, S., Rostamian, S., Steinbusch, H.W., van den Hove, Daniel LA, 666 
Prickaerts, J., 2013. Chronic phosphodiesterase type 2 inhibition improves memory in the 667 
APPswe/PS1dE9 mouse model of Alzheimer's disease. Neuropharmacology. 64, 124-136. 668 
Stargardt, A., Swaab, D.F., Bossers, K., 2015. The storm before the quiet: neuronal hyperactivity 669 
and Aβ in the presymptomatic stages of Alzheimer's disease. Neurobiol.Aging. 36, 1-11. 670 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
 
 27
Steardo Jr, L., Bronzuoli, M.R., Iacomino, A., Esposito, G., Steardo, L., Scuderi, C., 2015. Does 671 
neuroinflammation turn on the flame in Alzheimer's disease? Focus on astrocytes. 9. 672 
Stoiljkovic, M., Kelley, C., Hajós, G.P., Nagy, D., Koenig, G., Leventhal, L., Hajós, M., 2016. 673 
Hippocampal network dynamics in response to α7 nACh receptors activation in amyloid-β 674 
overproducing transgenic mice. Neurobiol.Aging. 675 
Sturchler-Pierrat, C., Abramowski, D., Duke, M., Wiederhold, K.H., Mistl, C., Rothacher, S., 676 
Ledermann, B., Burki, K., Frey, P., Paganetti, P.A., Waridel, C., Calhoun, M.E., Jucker, M., Probst, 677 
A., Staufenbiel, M., Sommer, B., 1997. Two amyloid precursor protein transgenic mouse models 678 
with Alzheimer disease-like pathology. Proc.Natl.Acad.Sci.U.S.A. 94, 13287-13292. 679 
Verret, L., Mann, E.O., Hang, G.B., Barth, A.M., Cobos, I., Ho, K., Devidze, N., Masliah, E., 680 
Kreitzer, A.C., Mody, I., 2012. Inhibitory interneuron deficit links altered network activity and 681 
cognitive dysfunction in Alzheimer model. Cell. 149, 708-721. 682 
Voytek, B., Knight, R.T., 2015. Dynamic network communication as a unifying neural basis for 683 
cognition, development, aging, and disease. Biol.Psychiatry. 77, 1089-1097. 684 
Voytek, B., Kramer, M.A., Case, J., Lepage, K.Q., Tempesta, Z.R., Knight, R.T., Gazzaley, A., 685 
2015. Age-Related Changes in 1/f Neural Electrophysiological Noise. J.Neurosci. 35, 13257-13265. 686 
Watrous, A.J., Deuker, L., Fell, J., Axmacher, N., 2015. Phase-amplitude coupling supports phase 687 
coding in human ECoG. Elife. 4, 10.7554/eLife.07886. 688 
Westmark, C.J., Westmark, P.R., Beard, A.M., Hildebrandt, S.M., Malter, J.S., 2008. Seizure 689 
susceptibility and mortality in mice that over-express amyloid precursor protein. 690 
Int.J.Clin.Exp.Pathol. 1, 157-168. 691 
Woolley, M., Ballard, T., 2005. Age-related impairments in operant DMTP performance in the 692 
PS2APP mouse, a transgenic mouse model of Alzheimer's disease. Behav.Brain Res. 161, 220-228. 693 
World Health Organization, 2015. Fact sheet N°362, March 2015. 694 
Xu, W., Fitzgerald, S., Nixon, R.A., Levy, E., Wilson, D.A., 2015. Early hyperactivity in lateral 695 
entorhinal cortex is associated with elevated levels of AβPP metabolites in the Tg2576 mouse 696 
model of Alzheimer's disease. Exp.Neurol. 264, 82-91. 697 
Zampese, E., Fasolato, C., Pozzan, T., Pizzo, P., 2011a. Presenilin-2 modulation of ER-698 
mitochondria interactions: FAD mutations, mechanisms and pathological consequences. 4, 357-360. 699 
Zampese, E., Fasolato, C., Kipanyula, M.J., Bortolozzi, M., Pozzan, T., Pizzo, P., 2011b. Presenilin 700 
2 modulates endoplasmic reticulum (ER)-mitochondria interactions and Ca2+ cross-talk. 701 
Proc.Natl.Acad.Sci.U.S.A. 108, 2777-2782. 702 
Zatti, G., Burgo, A., Giacomello, M., Barbiero, L., Ghidoni, R., Sinigaglia, G., Florean, C., Bagnoli, 703 
S., Binetti, G., Sorbi, S., 2006. Presenilin mutations linked to familial Alzheimer's disease reduce 704 
endoplasmic reticulum and Golgi apparatus calcium levels. Cell Calcium. 39, 539-550. 705 
Zhang, X., Zhong, W., Brankack, J., Weyer, S.W., Muller, U.C., Tort, A.B., Draguhn, A., 2016. 706 
Impaired theta-gamma coupling in APP-deficient mice. Sci.Rep. 6, 21948. 707 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
 
 28
Zou, C., Montagna, E., Shi, Y., Peters, F., Blazquez-Llorca, L., Shi, S., Filser, S., Dorostkar, M.M., 708 
Herms, J., 2015. Intraneuronal APP and extracellular Aβ independently cause dendritic spine 709 
pathology in transgenic mouse models of Alzheimer’s disease. Acta Neuropathol. 129, 909-920. 710 
  711 
  712 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
 
 29
9 FIGURE LEGENDS 713 
Figure 1. Power spectra of LFP signals recorded in vivo from the DG of wt, PS2-NI and PS2APP mice. Left: 714 
frequency distribution obtained as described in Methods at 3 (A), 6 (B) and 12 (C) months of age (mean, 715 
continuous line; SEM, dotted line, for legibility only one SEM is shown); insets, magnifications highlighting 716 
the Beta-Gamma frequency range. Right: Bars represent the average power at 3, 6 and 12 months of age 717 
for each genotype within the following discrete bands: Beta, 10 - 15 Hz (D), SG, 25 – 40 Hz (E) and FG, 40 – 718 
90 Hz (F); mean ± SEM, n =11, 8, 8 (3-months); 10, 12, 12 (6-months) and 9, 7, 9 (12-months) for wt, PS2-NI 719 
and PS2APP mice respectively; * p < 0.05; ** p < 0.01; Mann-Whitney rank-sum test. Unless specified, the 720 
mouse number is the same for all the other figures. 721 
Figure 2. Linear fitting of PSD from wt, PS2-NI and PS2APP mice. (A-C) The mean power spectrum of each 722 
genotype at 3, 6 and 12 months of age, obtained as shown in Figure 1, is reported along with the linear 723 
fitting (straight line) in the semi-log space. (D,E) Bar graphs summarizing the mean linear-fit slope 724 
coefficient (D) and the offset (E) in the range 10-100 Hz. Mean ± SEM; ° p = 0.06 * p < 0.05; ** p < 0.01; *** 725 
p < 0.001; **** p < 0.0001; Mann-Whitney rank-sum test. 726 
Figure 3. Analysis of Theta-higher frequency bands PAC. (A-D) Bar graphs report the mean PAC index 727 
(GLM) within the Theta-Beta (A), Theta-SG (B), Theta-FG (C) and Theta-Epsilon (D) classes for wt, PS2-NI and 728 
PS2APP mice at different ages. Mean ± SEM for wt, PS2-NI and PS2APP lines respectively; * p < 0.05; ** p < 729 
0.01; Mann-Whitney rank-sum test. 730 
Figure 4. Plaque deposition and astrogliosis in wt, PS2-NI and PS2APP mice. (A-C) Representative images 731 
of immunostaining for APP/Aβ with 4G8 (left) and astrogliosis with GFAP (right), obtained as described in 732 
Methods from wt (A), PS2-NI (B) and PS2APP (C) mice (Scale bar, 300 µm). (D) Bar graph represents the 733 
astrocyte reactivity evaluated on the basis of the GFAP staining intensity within the sub-regions indicated in 734 
panel A (dashed lines). CA, Cornu Ammonis; DG, Dentate Gyrus; Sb, Subiculum; scale bar, 300 µm. Mean ± 735 
SEM n = 3-4 animals (3 slices each) per genotype; * p < 0.05; Mann-Whitney rank-sum test. 736 
Figure 5. Intraneuronal APP/Aβ accumulation in 3-month-old PS2APP mice. (A) Representative image of 737 
APP/Aβ immunostaining (4G8) of sagittal hippocampal sections from 3-month-old PS2APP mice. 738 
Intracellular APP/Aβ accumulation is particularly strong in CA1 pyramidal layer and in the subiculum. Scale 739 
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bar, 300 µm. (B) Magnification (5x) of the subiculum region shown in A; n = 3 PS2APP mice (3 slices each). 740 
(C) Representative image of a 100x acquisition of the subiculum region co-stained for APP/Aβ and GFAP. 741 
Scale bar, 20 µm. 742 
Figure 6. PSD and steepness in PS2KO and APPSwe mice. (A,B) PSD functions in the log-log (A) and semi-743 
log (B) space  of wt (replicated from Figs. 1 and 2), PS2KO and APPSwe mice at 6 months of age (mean, 744 
continuous line; SEM, dotted line, for legibility only one SEM is shown). Straight lines in B represent PSD 745 
linear fittings. (C,D) The bar graphs report the mean power quantified in the Beta, SG and FG bands (C), and 746 
the mean linear-fit slope coefficient (D), measured in 6 month-old wt, PS2KO and APPSwe mice. Mean ± 747 
SEM, n = 10, 7, 5 for wt, PS2KO and APPSwe mice respectively; ** p < 0.01; Mann-Whitney rank-sum test. 748 
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HIGHLIGHTS 
• In vivo spontaneous LFP activity in dentate gyrus of PS2-based AD mouse models. 
• Enhanced Beta/Gamma power and spectral steepness early characterize PS2APP mice. 
• The spectral steepness increase anticipates plaque deposition and gliosis. 
• Power increase and CFC enhancement timely occur with AD histo-pathological traits. 
• Power and steepness increases are associated with mutant PS2 and APP, respectively. 
